More Suzhou Ribo Life Science Co. Ltd. news
Suzhou Ribo Life Science Co. Ltd.HKEX: 6938

Next Day Disclosure Return

Nov 16, 2026 at 7:09 AM EST · Issued by Suzhou Ribo Life Science Co. Ltd. via HKEXnews

Filed with HKEX · Stock code 6938 · Nov 16, 2026 at 7:09 AM EST · 6 pages · English

On 6ix: 6ix.com/news/next-day-disclosure-return-2863

Suzhou Ribo Life Science Co. Ltd. on 6ix

Earlier from Suzhou Ribo Life Science

  • Voluntary announcement - phase I clinical trial application submission of novel dual targeting siRNA SR122 for treatment of mixed dyslipidemia and severe hypertriglyceridemiaNov 9
  • Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026Nov 5
  • Discloseable and connected transaction acquisition of the remaining 49.71% shareholding in a subsidiary involving the issue of consideration shares under Specific mandate; and proposed change of registered capital and amendments to the articles of associationOct 19
All Suzhou Ribo Life Science news releases↗

Follow Suzhou Ribo Life Science into a list and get an email when it puts out news.

Follow Suzhou Ribo Life Science
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer